Resources

Research, perspectives, and patient stories from the site that brings clinical trials to people's homes.

Get Science 37 Direct-to-You

Sign up for our quarterly newsletter to receive industry insights, company news, and more, delivered straight to your inbox.
Subscription Form
Featured Research · Tufts CSDD

Evaluating the Impact of a Direct-to-Patient Clinical Trial Site on Performance, Access, and Patient Representation

The first peer-reviewed study comparing a direct-to-patient site with traditional industry benchmarks.
Read the Report
Published in Applied Clinical Trials
6x
More enrollment on average per trial
>50%
Higher completion of enrolled patients
121
Days faster, FPFV to database lock
3x
More Black participants
Published in Applied Clinical Trials

Evaluating the Impact of a Direct-to-Patient Clinical Trial Site on Performance, Access, and Patient Representation

Published in Applied Clinical Trials
Across 28 studies, Science 37 enrolled more patients, kept more of them, reached database lock sooner and brought in a more representative population.
Read the Peer-Reviewed Analysis
From Our CEO

Science 37 and the DCT Evolution

What we learned building, breaking, and rebuilding a clinical trials company.

"The lesson is not that market corrections are failures. It's that the companies that survive are the ones honest enough to admit when something isn't working and disciplined enough to actually reset."

Tyler Van Horn
Chief Executive Officer, Science 37

Read the Article

From the Blog

Patient advocates, clinicians and leaders on what it takes to make research accessible.

Patient Stories

Voices at the heart of our work.
Man and woman in black shirts sitting together on a couch at home, smiling at the camera

Fragile X Syndrome

Woman in a pink shirt smiling at the camera at home

Atrial Fibrillation

Man in a red, white, and blue tie-dye shirt smiling at home in front of a wooden display cabinetMan in a red, white, and blue tie-dye shirt smiling at home in front of a wooden display cabinet

Parkinson's Disease

Man wearing glasses and a plaid shirt, smiling at the camera indoors

Type 2 Diabetes

Woman seated on a beige couch at home, smiling and looking off-camera

Primary Biliary Cholangitis

Prader-Willi Syndrome

Hear More Stories From Our Participants

Our Direct-to-Patient Site in Action

Perspectives from our nurses, investigators and team members on the road and on camera, delivering trials to patients' homes.

Case Studies

Real-world examples of how our site has contributed to sponsor trials.

Company News

Discover the latest announcements, partnerships, and milestones from Science 37.

Articles, Publications & Other Media

Learn more about the impact of direct-to-patient clinical research.

Redefining Access in Clinical Trials Through Direct-to-Patient IMP Shipping

Decentralized clinical trials are transforming research by removing geographical barriers, expanding patient access, and making participation more flexible and inclusive.

Trust Through Execution
How Science 37 Expanded Patient Access Through Collaboration

Rare disease and pediatric clinical trials can place significant burdens on families through travel, caregiving, scheduling challenges, and long-term commitments.

Evaluating the Impact of a Direct-to-Patient Clinical Trial Site on Performance, Access, and Patient Representation

Evidence on direct-to-patient clinical trial models remains limited, although decentralized approaches show promise in improving access, enrollment, efficiency, and convenience.

Breaking Down Geographic Barriers in Clinical Research

Science 37 CEO Tyler Van Horn explains how home-based clinical trials improve patient access, simplify participation, and support better retention.

Get Science 37 Direct-to-You

Sign up for our quarterly newsletter to receive industry insights, company news, and more, delivered straight to your inbox.
Subscription Form
© 
2026
 Science 37 | All Rights Reserved